reports discussed here now clearly demonstrate that low-frequency polyspermy events are very likely contributors to polyploidization of plants. These reports do not rule out fast and/or slow blocks to polyspermy in plants. Moreover, they do not provide insight into the fundamental unanswered question of how each member of a pair of sperm cells delivered by a single pollen tube fuses with either the egg or the central cell (as in Figure 1B ) rather than both sperm cells fusing with one or the other female gamete. However, these two papers nicely demonstrate that plants have a strong, but not insurmountable, block to polyspermy on the egg cell and that the block to central cell polyspermy is less stringent. It will be interesting to see whether HIPOD and other approaches to select rare and potentially useful triparental combinations can be used to enhance crop plant breeding. 
5. Maruyama, D., Volz, R., Takeuchi, H., Mori, T., Igawa, T., Kurihara, D., Kawashima, T., Ueda, M., Ito, M., Umeda, M., et al. (2015) . Rapid elimination of the persistent synergid through a cell fusion mechanism. Cell 161, 907-918. Lipopolysaccharide synthesis and transport pathways are attractive targets for the development of new antimicrobial therapeutics. The ABC (ATP Binding Cassette) transporter MsbA has been recently described as employing a 'trap and flip' mechanism of lipopolysaccharide transport. This represents a novel mechanism amongst known lipid ABC transporters.
Many human pathogens, such as Escherichia coli and Salmonella, belong to a subset of bacteria called Gram-negatives. The cell envelope of Gram-negative bacteria is made up of three parts: the inner membrane, made up of a symmetric bilayer of glycerophospholipids; the periplasm, an aqueous compartment that contains the peptidoglycan layer; and the outer membrane, an asymmetric bilayer that functions to protect the bacteria from environmental, antibacterial, and immunological assault [1, 2] (Figure 1 ). The inner periplasmic leaflet of the outer membrane bilayer is composed of the same glycerophospholipids present in the inner membrane, whereas the outer leaflet is predominantly comprised of lipopolysaccharide (LPS) [2] .
Disruptions of this unique asymmetry results in the bacterium becoming susceptible to noxious compounds and effectors of the innate immune system, such as antimicrobial peptides and complement [3] . Many antibiotics are inherently ineffective against Gram-negative bacteria because the outer membrane functions as a physical barrier preventing 
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Dispatches the antibiotic from reaching its target [1] . With few exceptions (Neisseria, Moraxella, and Acinetobacter), LPS biosynthesis is thought to be essential for viability of Gram-negative organisms [4] [5] [6] . However, it is worth noting that even for those 'exceptions', loss of LPS makes these organisms highly susceptible to antibiotics and attack by the mammalian immune system. The in vitro growth rate of the lpx mutants was clearly diminished; furthermore, in vitro and in vivo competitive-growth experiments revealed a reduction in fitness for both mutant types [7, 8] . Thus, the molecular machinery required for the production and transport of LPS are attractive targets for the design of novel antibacterial therapeutics.
LPS is comprised of three parts, assembled in order: lipid A, coreoligosaccharide and O-antigen polysaccharide ( Figure 1 ). Assembly of the lipid A and core domains occurs either in the cytoplasm or at the cytoplasmic face of the inner membrane [2] . In 1991, the Georgopoulos group identified a gene required for bacterial survival at elevated temperatures called htrB (high temperature requirement protein B, now referred to as lpxL). They found that with the deletion of lpxL, bacteria were unable to grow at physiological temperatures, and showed an altered cellular morphology [9] . However, at the time the function of lpxL was not determined. Georgopoulos also showed that these lpxL knockout phenotypes could be rescued by the overexpression of either msbB (multi-copy suppressor of htrB, now referred to as lpxM), or a second multi-copy suppressor, msbA [10] . LpxL and LpxM had similar sequence identity, suggesting they had similar functions [10] . Later, the laboratory of Christian R. H. Raetz, the discoverer of the lipid A biosynthetic pathway, determined that LpxL and LpxM functioned as lipid A acyltransferases. Together, E. coli LpxL and LpxM convert the tetra-acylated lipid A precursor (Kdo 2 -lipid IV A ) to the hexaacylated lipid A anchor found at the bacterial surface ( Figure 1 ) [2] . Since LpxM (MsbB) can also acylate tetraacylated lipid A, albeit at a very slow rate, overexpression of LpxM can suppress the lpxL (htrB) mutation. [11] . In E. coli, the Kdo 2 -lipid A substructure of LPS is synthesized via the Raetz pathway. A total of nine enzymatic steps are required, but only the last two steps of Kdo 2 -lipid A biosynthesis are shown. Although the two Kdo sugars are part of the core-oligosaccharide, Kdo addition is required for the last steps of lipid A biosynthesis, which are catalyzed by two fatty acyl transferases. In E. coli, LpxL (HtrB) first adds a 12-carbon acyl chain, followed by the addition of a 14-carbon fatty acid by LpxM (MsbB), completing synthesis of the lipid A anchor. The remaining core-oligosaccharide is extended at the inner leaflet of the inner membrane and is then transported to the periplasmic face by the MsbA flippase. Ribbon diagrams of nucleotide-free (Protein Database 5TV4, www.rcsb.org/ pdb/explore.do?structureId=5tv4) and ADP-vanadate-bound MsbA (Protein Database 5TTP, www.rcsb.org/pdb/explore/explore.do?structureId=5ttp) structures are shown in light blue. For LPS bound to nucleotide-free MsbA, acyl chains shown in yellow, lipid A glucosamines shown in blue, lipid A phosphates in red, and core-oligosaccharide shown in grey. The addition of the O-antigen occurs in the periplasm (not shown for simplicity); however, not all organisms synthesize the O-antigen domain. Transport across the periplasm to the bacterial surface is carried out by the envelope-spanning Lpt (LPS transport) translocation machinery. LptD N and LptD C refer to the amino-and carboxy-terminal domains of LptD.
Unlike LpxM, the amino acid sequence for MsbA does not resemble LpxL [10, 12] . Instead, MsbA is an inner membrane ATPase. And unlike lpxM, msbA is an essential gene required for bacterial growth [12] , suggesting that MsbA has an active function in either LPS biosynthesis or transport [13] [14] [15] . Sequence comparison of MsbA revealed that it is conserved throughout bacteria and resembles eukaryotic MDR (multi-drug resistance) proteins [12, 16] . Rather than playing a role in the synthesis of the lipid A anchor of LPS, the function of MsbA is to 'flip' nascent LPS molecules from the cytoplasmic to the periplasmic leaflet of the inner membrane [14, 15] . This flipping step in LPS biosynthesis occurs after completion of the core-oligosaccharide. After transport across the inner membrane, the O-antigen is attached to the core-domain in the periplasm (not shown in Figure 1 ) resulting in fully formed LPS. From there, LPS is transported to the outer membrane via the lipopolysaccharide transport (Lpt) protein complex ( Figure 1 ) [2] .
Recently, a new mechanism for how MsbA transports nascent LPS across the inner membrane has been described [17] . Instead of X-ray crystallography to determine the structure of MsbA, Mi and co-workers used a powerful technique to image proteins called cryo-electron microscopy (cryo-EM). With cryo-EM, proteins can be imaged while in their native conformations. This is a significant advantage over X-ray crystallography where the proteins must be first precipitated into crystals, possibly misfolding the protein in the process. A timely application of this cryo-EM approach is highlighted by the recent 2017 Nobel Prize in Chemistry award given to the developers of cryo-EM. Both the potential of MsbA as a future antibiotic target and the close resemblance of MsbA to other transporters found in higher organisms highlight the importance of elucidating its mechanism of function [12] .
Crystal structures of MsbA from multiple bacterial species have been solved using protein solubilized in detergent micelles [18] . In these conditions, MsbA undergoes a very large conformational change as a result of ATP turnover. The resulting 'inward-outward' model represented a significant step forward in our understanding of how MsbA functions. In this model, MsbA without bound nucleotide is open and facing the cytoplasmic side of the inner membrane. Upon binding of an ATP mimic (ADP-vanadate), MsbA closes on the cytoplasmic side and opens on the periplasmic side of the inner membrane. This model suggests MsbA functions by forming a double-door allowing LPS to transverse the inner membrane. However, a major caveat of the previous MsbA structures was the lack of co-crystallization with their lipid substrate. Thus, determination of the MsbA structure with LPS substrate would strongly suggest MsbA is in its proper conformation.
To help maintain MsbA in its native conformation, Mi and coworkers used nanodiscs as an alternative approach to keep the membrane protein in solution without detergent [17] . Nanodiscs can be thought of as inner tubes (phospholipids) used to keep swimmers (proteins) floating in a pool (aqueous solution). Compared to the crystallized structures, MsbA in nanodiscs was found to undergo much smaller conformational changes, based on whether an ATP mimic (ADP-vanadate) or ADP/no nucleotide was bound. Strikingly, MsbA in nanodiscs contained LPS and displayed greater ATPase activity compared to MsbA in detergent micelles. This suggests that MsbA imbedded in nanodiscs represents a more native conformation of the protein compared to detergent micelles.
Structures of LPS bound to MsbA were unable to resolve a fully extended coreoligosaccharide due to the lack of stabilizing interactions occurring within the MsbA cavity [17] . The outer membrane primarily contains only one form of lipid A. If nascent LPS enters the MsbA cavity through diffusion from the cytoplasmic leaflet of the inner membrane, then the MsbA cavity would be a likely location for substrate specificity. If MsbA is non-specific for what form of nascent LPS it transports then many different LPS species bearing lipid A anchors with varying acylation states would be expected to be present within the outer membrane. Although MsbA is capable of transporting tetraacylated and penta-acylated lipid A, this only occurs when msbA is overexpressed. Exactly why MsbA appears to only transport fully formed lipid A with its extended core-oligosaccharide is still a topic yet to be resolved. Future studies are needed to fully determine the mechanism of MsbA specificity for LPS.
The new model of how MsbA functions is called a 'trap and flip' mechanism of transport. In this model, when ADP (or no nucleotide) is bound, MsbA is open to the cytoplasm, thus permitting LPS to enter the cavity. After LPS entry, MsbA closes like a clam shell around the LPS, aligning the nucleotide binding domains, followed by ATP hydrolysis. This triggers a conformational change and allows LPS to slip out the side of the MsbA into the periplasmic leaflet. After LPS exits the protein, the system resets and another LPS molecule can enter from the cytoplasmic side. The proposed mechanism of how LPS exits through the side of MsbA parallels how LPS exits the outer membrane protein complex of the Lpt pathway (LptDE) [19, 20] . Thus, it is conceivable that the mechanism used to flip LPS might be conserved for both the inner and outer membranes due to the unique structure of LPS. Overall, this new study from Mi and coworkers represents another major step forward in the understanding of how nascent LPS is permitted to cross the inner membrane to complete its synthesis.
Type 2 immunity at mucosal surfaces is thought to be initiated by type 2 innate lymphoid cells. New studies report that these cells are themselves activated by the neuropeptide neuromedin U, produced by cholinergic neurons in the gut and in airways.
Type 2 immunity is the arm of the immune system typically associated with both allergy and effective defense against helminth worm infections [1, 2] . Type 2 cells release a range of soluble multifaceted effector cytokines that accelerate intestinal nematode expulsion and wound repair, but also exacerbate disease in allergic patients when dysregulated. At the heart of type 2 immunity are two different lymphoidderived cells: T helper type 2 (Th2) cells of the adaptive immune axis (which release cytokines when activated through their antigen-specific receptors) and their mirror image in the innate immune system, type 2 innate lymphoid cells (ILC2s), which represent potent first responders to generic immune stimuli released at barrier surfaces [2, 3] .
ILC2s are local amplifiers of the type 2 immune response, releasing the key cytokine drivers of eosinophil infiltration (interleukin-5 (IL-5)) and of goblet and tuft cell hyperplasia (IL-13), as well as triggering fibrosis in response to signals such as alarmins secreted by epithelial cells [4] . Attention has focused on a troika of epithelial alarmins, namely: IL-33, a DNA-associated cytokine released upon cell damage; IL-25, produced by tuft cells in a taste-receptor signalingdependent manner; and thymic stromal lymphopoietin (TSLP), a predominant ILC2 activator in the skin [4, 5] . These mediators have been depicted in a simple bi-directional dialogue between stromal cells and immune cells that allows epithelial cells to flag and report an immune insult to ILC2s, which in turn instruct the epithelial barrier to condition itself against the immediate challenge, while kick-starting adaptive immunity to counteract chronic infections. A more profound network is
